4.2 Article

Design, synthesis, and biological evaluation of some 1,2,3-triazole derivatives as novel amide-based inhibitors of soluble epoxide hydrolase

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors

Elham Rezaee et al.

Summary: The study focused on designing, synthesizing and evaluating new amide-based derivatives of 3-phenylglutaric acid as potential sEH inhibitors. Most of the synthesized compounds showed nanomolar range inhibition against sEH enzyme, with the best observed IC50 value of 0.5 nM. Incorporating carboxylic moieties into the structures could increase solubility and improve physicochemical properties.

MOLECULAR DIVERSITY (2021)

Article Chemistry, Medicinal

Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative

Bruce D. Hammock et al.

Summary: This report describes the development of an orally active analgesic that can address inflammation and neuropathic pain without causing addiction. The medication stabilizes EpFA to reduce pain and inflammation, with human trials showing no drug-related adverse events. Additionally, the fundamental research leading to the discovery of this medication and its mechanism of action is outlined.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase

Iman Mahlooji et al.

ARCHIV DER PHARMAZIE (2020)

Review Endocrinology & Metabolism

Eicosanoids: Atherosclerosis and cardiometabolic health

Kimberly Piper et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2020)

Article Biochemistry & Molecular Biology

Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity

Kerstin Hiesinger et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)

Review Pharmacology & Pharmacy

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future

Bomina Park et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Environmental Sciences

The Role of Eicosanoids in Alzheimer's Disease

Roger G. Biringer

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)

Review Physiology

Epoxyeicosanoids in Hypertension

J. D. Imig

PHYSIOLOGICAL RESEARCH (2019)

Review Chemistry, Medicinal

Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis

Zehra Tugce Gur et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics

John D. Imig

PHARMACOLOGY & THERAPEUTICS (2018)

Review Multidisciplinary Sciences

Synopsis of arachidonic acid metabolism: A review

Violette Said Hanna et al.

JOURNAL OF ADVANCED RESEARCH (2018)

Review Allergy

Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?

Marek Sanak

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2016)

Review Pharmacology & Pharmacy

The role of epoxyeicosatrienoic acids in the cardiovascular system

L. Yang et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)

Article Physiology

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension

Marlina Manhiani et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)

Article Biochemical Research Methods

Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies

PD Jones et al.

ANALYTICAL BIOCHEMISTRY (2005)

Article Chemistry, Medicinal

Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility

IH Kim et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)